CJEU outlines scope of rights for plant variety owners
19-12-2019
Alessandro Zappalorto / Shutterstock.com
The Court of Justice of the European Union (CJEU) has rejected two appeals that would have restricted the European Medicines Agency’s right to publish a pharmaceutical company’s clinical trial data, as it relates to their applications to market their products within the EU.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Court of Justice of the European Union, CJEU, appeals, European Medicines Agency, EMA, pharmaceutical, clinical trial data, EU, PTC Therapeutics
